FDA says GE Healthcare has determined there is no risk of elevated levels of formaldehyde from using its EVair compressor and restrictions on its use ...
FDA approves Protega Pharmaceuticals Roxybond (oxycodone hydrochloride), an abuse-deterrent, immediate-release 10 mg tablet for managing pain.
A Canadian Health Policy Institute analysis says U.S. drug importation programs developed by state governments will not be able to achieve the consume...
FDA grants an accelerated approval to Novartis for its supplemental NDA for Scemblix (asciminib) for the drugs expanded use in treating newly diagnose...
Former president Donald Trump appears to be leaning toward elevating former presidential candidate and now supporter Robert F. Kennedy, Jrs health rol...
FDA says it no longer requires a cardiovascular outcome trial for Vivus Qsymia weight-loss pill.
FDA sends PharmaTher a complete response letter on its ANDA for Ketarx (ketamine) and its use in anesthesia, sedation, and pain, among other uses.
